Ironwood Pharmaceuticals Inc (IRWD) — Cash Flow Reinvestment Rate
Ironwood Pharmaceuticals Inc (IRWD) has a Cash Flow Reinvestment Rate of 0.00x as of June 2026, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $58.28 Million. See Ironwood Pharmaceuticals Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ironwood Pharmaceuticals Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Ironwood Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see how efficiently does Ironwood Pharmaceuticals Inc generate cash.
Annual Cash Flow Reinvestment Rate for Ironwood Pharmaceuticals Inc (2019–2025)
Year-by-year capital reinvestment analysis for Ironwood Pharmaceuticals Inc. See financial flexibility index of Ironwood Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | $34.00K | $127.04 Million | $34.00K | ▼ -90.2% |
| 2024 | 0.00x | $284.00K | $103.55 Million | $142.00K | ▼ -100.0% |
| 2023 | 5.57x | $1.02 Billion | $183.43 Million | $273.00K | ▲ +560887.6% |
| 2022 | 0.00x | $272.00K | $273.76 Million | $136.00K | ▼ -50.9% |
| 2021 | 0.00x | $530.00K | $261.89 Million | $265.00K | ▼ -90.7% |
| 2020 | 0.02x | $3.68 Million | $168.84 Million | $1.84 Million | ▼ -98.7% |
| 2019 | 1.71x | $18.33 Million | $10.72 Million | $7.19 Million | — |